Influence of overweight and obesity on the development of reproductive disorders in women

Main Article Content

O.S. Payenok


Obesity remains a serious health problem in all count­ries due to its prevalence and the development of significant health consequences associated with high morbidity and mortality. According to the World Health Organization, over 1.5 billion adults in the modern world are overweight. According to domestic studies, about 40 % of the population of Ukraine is overweight and 25 % is obese. The literature review focuses on the problem of obesity in the peri- and postmenopausal periods. Because adipose tissue is the site of conversion of bioactive estrogens from androgenic precursors, it could be assumed that obese women should be less likely to deve­lop symptoms of menopausal disorders such as vascular disorders, osteo­porosis. Obesity affects ovulation, oocyte maturation, proces­ses in the endometrium, and the process of implantation. Obesity impairs reproductive function not only through the mechanisms of ovulation disorders: reduced fertility is observed in patients with re­gular ovulatory cycles. Other mechanisms (the complex influence of psychosocial factors; the level of proinflammatory cytokines secre­ted by adipose tissue is increased in obesity) have not only a direct embryotoxic effect, but also limit the invasion of the trophoblast, disrupting its normal formation. Excessive amounts of pro-inflammatory cytokines lead to local activation of prothrombinase and as a result to thrombosis, trophoblast infarction, its detachment and, ultimately, early miscarriage. The relationship between obesity and reproductive dysfunction has long been proven. At the same time, weight loss is known to improve this function in overweight and obese women. It is especially important that women with this pathology, who visit specialist physicians, receive the necessary re­commendations and support aimed at weight loss.

Article Details

How to Cite
Payenok, O. “Influence of Overweight and Obesity on the Development of Reproductive Disorders in Women”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 17, no. 7, Jan. 2022, pp. 575-80, doi:10.22141/2224-0721.17.7.2021.244974.
Literature Review


Wang Y, Beydoun MA, Min J, Xue H, Kaminsky LA, Cheskin LJ. Has the prevalence of overweight, obesity and central obesity levelled off in the United States? Trends, patterns, disparities, and future projections for the obesity epidemic. Int J Epidemiol. 2020 Jun 1;49(3):810-823. doi:10.1093/ije/dyz273.

Dereń K, Wyszyńska J, Nyankovskyy S, et al. Secular Trends of Underweight, Overweight, and Obesity in Children and Adolescents from Ukraine. Int J Environ Res Public Health. 2021 Mar 23;18(6):3302. doi:10.3390/ijerph18063302.

Tauqeer Z, Gomez G, Stanford FC. Obesity in women: insights for the clinician. J Womens Health (Larchmt). 2018 Apr;27(4):444-457. doi:10.1089/jwh.2016.6196.

Kanguru L, McCaw-Binns A, Bell J, Yonger-Coleman N, Wilks R, Hussein J. The burden of obesity in women of reproductive age and in pregnancy in a middle-income setting: a population based study from Jamaica. PLoS One. 2017 Dec 13;12(12):e0188677. doi:10.1371/journal.pone.0188677.

Pantasri T, Norman RJ. The effects of being overweight and obese on female reproduction: a review. Gynecol Endocrinol. 2014 Feb;30(2):90-94. doi:10.3109/09513590.2013.850660.

Zhou X, Yang X. Association between obesity and oligomenorrhea or irregular menstruation in Chinese women of childbearing age: a cross-sectional study. Gynecol Endocrinol. 2020 Dec;36(12):1101-1105. doi:10.1080/09513590.2020.1803823.

Seif MW, Diamond K, Nickkho-Amiry M. Obesity and menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2015 May;29(4):516-527. doi:10.1016/j.bpobgyn.2014.10.010.

Xu H, Li PH, Barrow TM, et al. Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: Results from Project ELEFANT. PLoS One. 2018 Nov 28;13(11):e0207929. doi:10.1371/journal.pone.0207929.

Ko KM, Han K, Chung YJ, Yoon KH, Park YG, Lee SH. Association between Body Weight Changes and Menstrual Irregularity: The Korea National Health and Nutrition Examination Survey 2010 to 2012. Endocrinol Metab (Seoul). 2017 Jun;32(2):248-256. doi:10.3803/EnM.2017.32.2.248.

Lee SS, Kim DH, Nam GE, et al. Association between metabolic syndrome and menstrual irregularity in middle-aged korean women. Korean J Fam Med. 2016 Jan;37(1):31-36. doi:10.4082/kjfm.2016.37.1.31.

Stracciolini A, Quinn BJ, Geminiani E, et al. Body mass index and menstrual patterns in dancers. Clin Pediatr (Phila). 2017 Jan;56(1):49-54. doi:10.1177/0009922816642202.

Silvestris E, de Pergola G, Rosania R, Loverro G. Obesity as disruptor of the female fertility. Reprod Biol Endocrinol. 2018 Mar 9;16(1):22. doi:10.1186/s12958-018-0336-z.

Catalano PM. Obesity, insulin resistance, and pregnancy outcome. Reproduction. 2010 Sep;140(3):365-371. doi:10.1530/REP-10-0088.

Kazemi M, Jarrett BY, Vanden Brink H, et al. Obesity, insulin resistance, and hyperandrogenism mediate the link between poor diet quality and ovarian dysmorphology in reproductive-aged women. Nutrients. 2020 Jun 30;12(7):1953. doi:10.3390/nu12071953.

Tong Q, Xu Y. Central Leptin Regulation of Obesity and Fertility. Curr Obes Rep. 2012 Dec 1;1(4):236-244. doi:10.1007/s13679-012-0025-8.

Atteia HH, Alzahrani S, El-Sherbeeny NA, et al. Evening primrose oil ameliorates hyperleptinemia and reproductive hormone disturbances in obese female rats: impact on estrus cyclicity. Front Endocrinol (Lausanne). 2020 Jan 30;10:942. doi:10.3389/fendo.2019.00942.

Broughton DE, Moley KH. Obesity and female infertility: potential mediators of obesity's impact. Fertil Steril. 2017 Apr;107(4):840-847. doi:10.1016/j.fertnstert.2017.01.017.

Hausman GJ, Barb CR, Lents CA. Leptin and reproductive function. Biochimie. 2012 Oct;94(10):2075-2081. doi:10.1016/j.biochi.2012.02.022.

Donato J Jr, Cravo RM, Frazão R, Elias CF. Hypothalamic sites of leptin action linking metabolism and reproduction. Neuroendocrinology. 2011;93(1):9-18. doi:10.1159/000322472.

Garcia-Galiano D, Allen SJ, Elias CF. Role of the adipocyte-derived hormone leptin in reproductive control. Horm Mol Biol Clin Investig. 2014 Sep;19(3):141-149. doi:10.1515/hmbci-2014-0017.

Bellefontaine N, Chachlaki K, Parkash J, et al. Leptin-dependent neuronal NO signaling in the preoptic hypothalamus facilitates reproduction. J Clin Invest. 2014 Jun;124(6):2550-2559. doi:10.1172/JCI65928.

Dobrzyn K, Smolinska N, Kiezun M, et al. Adiponectin: a new regulator of female reproductive system. Int J Endocrinol. 2018 Apr 29;2018:7965071. doi:10.1155/2018/7965071.

Kruszyńska A, Słowińska-Srzednicka J, Jeske W, Zgliczyński W. Proinsulin, adiponectin and hsCRP in reproductive age women with polycystic ovary syndrome (PCOS) - the effect of metformin treatment. Endokrynol Pol. 2014;65(1):2-10. doi:10.5603/EP.2014.0001.

Cheng L, Shi H, Jin Y, et al. Adiponectin deficiency leads to female subfertility and ovarian dysfunctions in mice. Endocrinology. 2016 Dec;157(12):4875-4887. doi:10.1210/en.2015-2080.

Sominsky L, Hodgson DM, McLaughlin EA, Smith R, Wall HM, Spencer SJ. Linking stress and infertility: a novel role for ghrelin. endocr rev. 2017 Oct 1;38(5):432-467. doi:10.1210/er.2016-1133.

Tena-Sempere M. Interaction between energy homeostasis and reproduction: central effects of leptin and ghrelin on the reproductive axis. Horm Metab Res. 2013 Dec;45(13):919-927. doi:10.1055/s-0033-1355399.

Dupont J, Maillard V, Coyral-Castel S, Ramé C, Froment P. Ghrelin in female and male reproduction. Int J Pept. 2010;2010:158102. doi:10.1155/2010/158102.

Zhang W, Lei Z, Su J, Chen S. Expression of ghrelin in the porcine hypothalamo-pituitary-ovary axis during the estrous cycle. Anim Reprod Sci. 2008 Dec;109(1-4):356-367. doi:10.1016/j.anireprosci.2007.12.020.

Zhang D, Yang X, Li J, Yu J, Wu X. Effect of hyperinsulinaemia and insulin resistance on endocrine, metabolic and fertility outcomes in women with polycystic ovary syndrome undergoing ovulation induction. Clin Endocrinol (Oxf). 2019 Sep;91(3):440-448. doi:10.1111/cen.14050.

De Wilde MA, Goverde AJ, Veltman-Verhulst SM, et al. Insulin action in women with polycystic ovary syndrome and its relation to gestational diabetes. Hum Reprod. 2015 Jun;30(6):1447-1453. doi:10.1093/humrep/dev072.

Sim KA, Partridge SR, Sainsbury A. Does weight loss in overweight or obese women improve fertility treatment outcomes? A systematic review. Obes Rev. 2014 Oct;15(10):839-850. doi:10.1111/obr.12217.

Tremellen K, Wilkinson D, Savulescu J. Should obese women's access to assisted fertility treatment be limited? A scientific and ethical analysis. Aust N Z J Obstet Gynaecol. 2017 Oct;57(5):569-574. doi:10.1111/ajo.12600.

Dağ ZÖ, Dilbaz B. Impact of obesity on infertility in women. J Turk Ger Gynecol Assoc. 2015 Jun 1;16(2):111-117. doi:10.5152/jtgga.2015.15232.

Santoro N, Lasley B, McConnell D, et al. Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study. J Clin Endocrinol Metab. 2004 Jun;89(6):2622-2631. doi:10.1210/jc.2003-031578.

Gorbatenko NV, Bezhenar VF, Fishman MB. Obesity and reproductive health of women. Obesity and metabolism. 2017;14(1):3-8. doi:10.14341/omet201713-8. (in Russian).

Best D, Avenell A, Bhattacharya S. How effective are weight-loss interventions for improving fertility in women and men who are overweight or obese? A systematic review and meta-analysis of the evidence. Hum Reprod Update. 2017 Nov 1;23(6):681-705. doi:10.1093/humupd/dmx027.

Paulson M, Sahlin L, Hirschberg AL. progesterone receptors and proliferation of the endometrium in obese women with polycystic ovary syndrome - a lifestyle intervention study. J Clin Endocrinol Metab. 2017 Apr 1;102(4):1244-1253. doi:10.1210/jc.2016-3155.

Pashkovska NV, Pankiv VI, Pashkovska OV. Obesity and Alzheimer’s disease. Mìžnarodnij endokrinologìčnij žurnal. 2020;16(1):3-9. doi:10.22141/2224-0721.16.1.2020.199121. (in Ukrainian).

Payenok OS, Payenok AV, Pankiv IV,Kostiv MO. Changes in lipid peroxidation and antioxidant activity in pregnant women and women in labour with diffuse toxic goiter. World of Medicine and Biology. 2019;2(68):85-91. doi:10.26724/2079-8334-2019-2-68-85-91. (in Ukrainian).

Semenyna GB, Pankiv VI, Pashkovska NV, Korytko OO, Pankiv IV. Ovarial factors in the pathogenesis of chronic anovulation in polycystic ovary syndrome. Problems of Endocrine Pathology. 2020;71(1):65-71. doi:10.21856/j-PEP.2020.1.09. (in Ukrainian).